JF
INBX

Jump Financial’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Jump Financial’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,509
Closed -$481K – 2297
2023
Q1 		$481K Sell
25,509
-7,609
-23% -$177K 0.02% 912
2022
Q4 		$816K Buy
33,118
+22,468
+211% +$660K 0.04% 571
2022
Q3 		$191K Sell
10,650
-20,613
-66% -$372K 0.01% 1357
2022
Q2 		$355K Buy
31,263
+8,463
+37% +$125K 0.02% 997
2022
Q1 		$508K Buy
22,800
+7,700
+51% +$197K 0.02% 804
2021
Q4 		$659K Buy
+15,100
New +$604K 0.04% 539

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Jump Financial's INBX Position: Q2 2023 in Review

Jump Financial sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2023, closing a stake of 25,509 shares — an estimated $481K sold.

Jump Financial first reported a position in INBX in Q4 2021 and held it in 6 quarters. The position peaked at $816K in Q4 2022. 107 funds tracked by Wall St. Rank hold INBX as of Q2 2023.

  • Jump Financial reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jump Financial sold 25,509 Inhibrx, Inc. Common Stock shares in Q2 2023, an estimated $481K.
  • Jump Financial first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Jump Financial's Inhibrx, Inc. Common Stock position peaked at $816K in Q4 2022.
  • 107 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2023.

Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.